Pacific Ridge Capital Partners’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,020
| Closed | -$1.14M | – | 134 |
|
|
2023
Q1 | $1.14M | Sell |
11,020
-70
| -0.6% | -$7.76K | 0.28% | 92 |
|
|
2022
Q4 | $1.28M | Hold |
11,090
| – | – | 0.3% | 80 |
|
|
2022
Q3 | $1.2M | Buy |
11,090
+1,940
| +21% | +$278K | 0.31% | 81 |
|
|
2022
Q2 | $1.65M | Sell |
9,150
-50
| -0.5% | -$8.95K | 0.39% | 73 |
|
|
2022
Q1 | $1.57M | Buy |
9,200
+990
| +12% | +$187K | 0.3% | 77 |
|
|
2021
Q4 | $1.72M | Hold |
8,210
| – | – | 0.31% | 80 |
|
|
2021
Q3 | $1.58M | Buy |
8,210
+2,490
| +44% | +$612K | 0.29% | 78 |
|
|
2021
Q2 | $1.62M | Buy |
5,720
+550
| +11% | +$149K | 0.29% | 76 |
|
|
2021
Q1 | $1.09M | Buy |
5,170
+850
| +20% | +$203K | 0.21% | 94 |
|
|
2020
Q4 | $848K | Sell |
4,320
-1,050
| -20% | -$186K | 0.21% | 96 |
|
|
2020
Q3 | $883K | Hold |
5,370
| – | – | 0.25% | 89 |
|
|
2020
Q2 | $745K | Buy |
5,370
+1,390
| +35% | +$128K | 0.2% | 93 |
|
|
2020
Q1 | $249K | Hold |
3,980
| – | – | 0.09% | 116 |
|
|
2019
Q4 | $436K | Buy |
+3,980
| New | +$385K | 0.1% | 125 |
|
|
2017
Q3 | – | Sell |
-101,578
| Closed | -$4.21M | – | 138 |
|
|
2017
Q2 | $4.21M | Sell |
101,578
-7,260
| -7% | -$316K | 1.24% | 27 |
|
|
2017
Q1 | $4.83M | Buy |
108,838
+19,698
| +22% | +$848K | 1.37% | 21 |
|
|
2016
Q4 | $3.71M | Sell |
89,140
-2,280
| -2% | -$91.8K | 1.33% | 23 |
|
|
2016
Q3 | $3.46M | Sell |
91,420
-3,090
| -3% | -$111K | 1.42% | 19 |
|
|
2016
Q2 | $3.14M | Sell |
94,510
-4,100
| -4% | -$132K | 1.42% | 16 |
|
|
2016
Q1 | $2.98M | Buy |
98,610
+370
| +0.4% | +$10.8K | 1.33% | 20 |
|
|
2015
Q4 | $2.98M | Buy |
98,240
+4,680
| +5% | +$139K | 1.34% | 22 |
|
|
2015
Q3 | $2.51M | Sell |
93,560
-2,362
| -2% | -$68.8K | 1.23% | 26 |
|
|
2015
Q2 | $3.1M | Sell |
95,922
-3,184
| -3% | -$101K | 1.29% | 20 |
|
|
2015
Q1 | $2.97M | Buy |
99,106
+2,880
| +3% | +$91.4K | 1.18% | 28 |
|
|
2014
Q4 | $3.23M | Buy |
96,226
+12,560
| +15% | +$391K | 1.37% | 17 |
|
|
2014
Q3 | $2.75M | Buy |
83,666
+13,316
| +19% | +$409K | 1.42% | 14 |
|
|
2014
Q2 | $2.14M | Sell |
70,350
-14,780
| -17% | -$461K | 1.46% | 15 |
|
|
2014
Q1 | $2.48M | Buy |
85,130
+850
| +1% | +$22.8K | 1.7% | 6 |
|
|
2013
Q4 | $2.2M | Buy |
+84,280
| New | +$2.16M | 1.49% | 16 |
|
Other funds holding MED
Pacific Ridge Capital Partners's MED Position: Q2 2023 in Review
Pacific Ridge Capital Partners sold out of Medifast (MED) in Q2 2023, closing a stake of 11,020 shares — an estimated $1.14M sold.
Pacific Ridge Capital Partners first reported a position in MED in Q4 2013 and held it in 29 quarters. The position peaked at $4.83M in Q1 2017. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.
- Pacific Ridge Capital Partners reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
- Pacific Ridge Capital Partners sold 11,020 Medifast shares in Q2 2023, an estimated $1.14M.
- Pacific Ridge Capital Partners first reported a position in Medifast in Q4 2013 and held it in 29 quarters.
- Pacific Ridge Capital Partners's Medifast position peaked at $4.83M in Q1 2017.
- 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.
Based on Pacific Ridge Capital Partners's 13F filing for Q2 2023, filed 10 Aug 2023.